Cargando…

Cell engineering techniques improve pharmacology of cellular therapeutics

Despite the rapid growth of clinical trials for cellular therapy worldwide, their clinical success is still afflicted with formidable challenges demanding conceptual and technological overhaul. Pharmacology, which is conventionally divided into pharmacokinetics (PK) and pharmacodynamics (PD) in drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Kaini, Du, Yanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934495/
https://www.ncbi.nlm.nih.gov/pubmed/36824659
http://dx.doi.org/10.1016/j.bbiosy.2021.100016
_version_ 1784889899804000256
author Liang, Kaini
Du, Yanan
author_facet Liang, Kaini
Du, Yanan
author_sort Liang, Kaini
collection PubMed
description Despite the rapid growth of clinical trials for cellular therapy worldwide, their clinical success is still afflicted with formidable challenges demanding conceptual and technological overhaul. Pharmacology, which is conventionally divided into pharmacokinetics (PK) and pharmacodynamics (PD) in drug discovery have emerged as a prominent research direction to elucidate the cell fate and ensure the efficacy and safety of the therapeutic cells. Herein, we concisely present the dilemmas of cellular therapies, the concept of cell pharmacology, and the advances in cell engineering that leverage the cell formulation technologies to modulate cellular PK/PD for development of more cogent and versatile cell-based therapies.
format Online
Article
Text
id pubmed-9934495
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99344952023-02-22 Cell engineering techniques improve pharmacology of cellular therapeutics Liang, Kaini Du, Yanan Biomater Biosyst VSI: Leading Opinion Paper Despite the rapid growth of clinical trials for cellular therapy worldwide, their clinical success is still afflicted with formidable challenges demanding conceptual and technological overhaul. Pharmacology, which is conventionally divided into pharmacokinetics (PK) and pharmacodynamics (PD) in drug discovery have emerged as a prominent research direction to elucidate the cell fate and ensure the efficacy and safety of the therapeutic cells. Herein, we concisely present the dilemmas of cellular therapies, the concept of cell pharmacology, and the advances in cell engineering that leverage the cell formulation technologies to modulate cellular PK/PD for development of more cogent and versatile cell-based therapies. Elsevier 2021-04-08 /pmc/articles/PMC9934495/ /pubmed/36824659 http://dx.doi.org/10.1016/j.bbiosy.2021.100016 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle VSI: Leading Opinion Paper
Liang, Kaini
Du, Yanan
Cell engineering techniques improve pharmacology of cellular therapeutics
title Cell engineering techniques improve pharmacology of cellular therapeutics
title_full Cell engineering techniques improve pharmacology of cellular therapeutics
title_fullStr Cell engineering techniques improve pharmacology of cellular therapeutics
title_full_unstemmed Cell engineering techniques improve pharmacology of cellular therapeutics
title_short Cell engineering techniques improve pharmacology of cellular therapeutics
title_sort cell engineering techniques improve pharmacology of cellular therapeutics
topic VSI: Leading Opinion Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934495/
https://www.ncbi.nlm.nih.gov/pubmed/36824659
http://dx.doi.org/10.1016/j.bbiosy.2021.100016
work_keys_str_mv AT liangkaini cellengineeringtechniquesimprovepharmacologyofcellulartherapeutics
AT duyanan cellengineeringtechniquesimprovepharmacologyofcellulartherapeutics